Citation Impact
Citing Papers
Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer
2006
Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers
2011
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Cancer statistics, 2022
2022 Standout
Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer
2012
Cancer statistics, 2023
2023 Standout
Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
2015
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Cancer statistics, 2024
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
After Cystectomy, Is It Justified to Perform a Bladder Replacement for Patients with Lymph Node Positive Bladder Cancer?
2002
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
2007 Standout
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2–4 pN+ Prostate Cancer: Results of a Matched Analysis
2011
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
2011
Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer
2010
Cancer‐specific survival after radical cystectomy and standardized extended lymphadenectomy for node‐positive bladder cancer: prediction by lymph node positivity and density
2009
Prospective Health-related Quality of Life Analysis for Patients Undergoing Radical Cystectomy and Urinary Diversion
2014
Host tissue determinants of tumour immunity
2019
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Mapping of Pelvic Lymph Node Metastases in Prostate Cancer
2012
Long-term results of standard procedures in urology: the ileal neobladder
2006
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy
2007
The molecular machinery of regulated cell death
2019 Standout
Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states
2008
Do Patients Benefit from Routine Follow-up to Detect Recurrences After Radical Cystectomy and Ileal Orthotopic Bladder Substitution?
2010
Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure
2006
Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice
2010
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Innovation in the pharmaceutical industry: New estimates of R&D costs
2016 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A New Multimodality Technique Accurately Maps the Primary Lymphatic Landing Sites of the Bladder
2009
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
2014
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy
2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
2016
Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer
2010
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
α-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma
2010
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Percentage of positive biopsies predicts lymph node involvement in men with low‐risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy
2010
11C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms
2008
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Peptide therapeutics: current status and future directions
2014 Standout
Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer
2007
Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis
2014
Anatomic Basis for Lymph Node Counts as Measure of Lymph Node Dissection Extent: A Cadaveric Study
2013
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells
2007
Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging: A Critical Analysis of the Literature
2011
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
2011
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Artificial intelligence in medicine
2017 Standout
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
2014 Standout
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
2020
Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions
2007
Insights into bombesin receptors and ligands: Highlighting recent advances
2015
Inhibitory effects of a dietary phytochemical 3,3′-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats
2008
Computer-aided Detection of Prostate Cancer with MRI
2016
Ureteral and Urethral Frozen Sections During Radical Cystectomy or Cystoprostatectomy: An Analysis of Denudation and Atypia
2014
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The significant role of mast cells in cancer
2011
CD10+ Pancreatic Stellate Cells Enhance the Progression of Pancreatic Cancer
2010
A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
2012
Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy
2008
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
2012
A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
2015
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Risk-adapted strategy for the kidney-sparing management of upper tract tumours
2015
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature
2012
Comparing Expert Reported Outcomes to National Surgical Quality Improvement Program Risk Calculator-Predicted Outcomes: Do Reporting Standards Differ?
2015
Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer
2007
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
2011
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Novel benzo-bis(1,2,5-thiadiazole) fluorophores for in vivo NIR-II imaging of cancer
2016
Results with radical cystectomy for treating bladder cancer: a ‘reference standard’ for high‐grade, invasive bladder cancer
2003
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results
2010
PRIMARY T1G3 BLADDER CANCER: ORGAN PRESERVING APPROACH OR IMMEDIATE CYSTECTOMY?
2004
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer
2006
Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection
2008
Bladder Cancer
2020 Standout
Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire
2016
Targeted Delivery of Multifunctional Magnetic Nanoparticles
2007
Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance
2014
The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals.
2007
PROSPECTIVELY PACKAGED LYMPH NODE DISSECTIONS WITH RADICAL CYSTECTOMY: EVALUATION OF NODE COUNT VARIABILITY AND NODE MAPPING
2004
Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells
2013
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Utility and significance of ureteric frozen section analysis during radical cystectomy
2015
Prospective comparison of quality‐of‐life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model
2013
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Segmental Ureterectomy Can Safely be Performed in Patients With Transitional Cell Carcinoma of the Ureter
2010
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Urinary Functional Outcome Following Radical Cystoprostatectomy and Ileal Neobladder Reconstruction in Male Patients
2012
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Development of individualized anti-metastasis strategies by engineering nanomedicines
2015
Near-infrared fluorophores for biomedical imaging
2017 Standout
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
2010
Is There a Therapeutic Role for Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Metastatic Transitional Cell Carcinoma of the Bladder?
2003
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of Achim Fleischmann being referenced
Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours
2011
Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down‐regulated in matched lymph node metastases
2010
Elective management of transitional cell carcinoma of the distal ureter: can kidney‐sparing surgery be advised?
2007
Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node‐positive bladder cancer
2011
MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor
2016
Is Pelvic Lymph Node Dissection Necessary in Patients with a Serum PSA<10ng/ml Undergoing Radical Prostatectomy for Prostate Cancer?
2006
Radical Cystectomy with an Extended Pelvic Lymphadenectomy: Rationale and Results
2007
Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer
2013
Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR Imaging
2014
Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization
2005
Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival
2008
Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: Molecular basis for dual targeting of tumoral vasculature
2011
Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis
2009
Overexpression of Gastrin‐Releasing Peptide Receptors in Tumor‐Associated Blood Vessels of Human Ovarian Neoplasms
2007
Targeting GRPR in urological cancers—from basic research to clinical application
2013
Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer
2010
Good Outcome for Patients with Few Lymph Node Metastases After Radical Retropubic Prostatectomy
2008
Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients
2009
Bombesin Receptors in Distinct Tissue Compartments of Human Pancreatic Diseases
2000
The Molecular Signature of the Stroma Response in Prostate Cancer-Induced Osteoblastic Bone Metastasis Highlights Expansion of Hematopoietic and Prostate Epithelial Stem Cell Niches
2014
Nerve Sparing Open Radical Retropubic Prostatectomy—Does It Have an Impact on Urinary Continence?
2006
Extracapsular Extension of Pelvic Lymph Node Metastases From Urothelial Carcinoma of the Bladder Is an Independent Prognostic Factor
2005
PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY
2001
PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY
2001
Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases
2008
[A normal thyroid gland upon autopsy: a relatively uncommon finding].
1999
Is There an Indication for Frozen Section Examination of the Ureteral Margins During Cystectomy for Transitional Cell Carcinoma of the Bladder?
2006
Diffusion-Weighted Magnetic Resonance Imaging Detects Significant Prostate Cancer with High Probability
2014
Twenty Years Experience With an Ileal Orthotopic Low Pressure Bladder Substitute—Lessons to be Learned
2006
Gastrin-Releasing Peptide Receptors in Normal and Neoplastic Human Uterus: Involvement of Multiple Tissue Compartments
2005
Distinct Subcellular Expression Patterns of Neutral Endopeptidase (CD10) in Prostate Cancer Predict Diverging Clinical Courses in Surgically Treated Patients
2008